Literature DB >> 13622614

Myasthenic-like features of neuromuscular transmission after administration of an inhibitor of acetylcholine synthesis.

J E DESMEDT.   

Abstract

Entities:  

Keywords:  ACETYLCHOLINE/antagonists; MYONEURAL JUNCTION/effect of drugs on; POISONS/effects

Mesh:

Substances:

Year:  1958        PMID: 13622614     DOI: 10.1038/1821673a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  MYASTHENIA GRAVIS WITH HYPERGAMMAGLOBULINAEMIA AND ANTIBODIES.

Authors:  H J OOSTERHUIS; H VAN DER GELD; T E FELTKAMP; F PEETOOM
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-08       Impact factor: 10.154

2.  QUATERNARY NITROGEN BASES IN HUMAN THYMUS GLANDS.

Authors:  T N CALVEY; A WILSON
Journal:  Br Med J       Date:  1963-08-24

3.  An electrophysiologic study of the neuromuscular junction in myasthenia gravis.

Authors:  O DAHLBACK; D ELMQVIST; T R JOHNS; S RADNER; S THESLEFF
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

4.  Myasthenia Gravis.

Authors:  I T Draper
Journal:  Postgrad Med J       Date:  1965-06       Impact factor: 2.401

5.  Actions of triethylcholine on neuromuscular transmission. 1961.

Authors:  W C Bowman; M J Rand
Journal:  Br J Pharmacol       Date:  1997-02       Impact factor: 8.739

6.  Applied electrophysiology in nerve and muscle disease. Disorders of neuromuscular transmission.

Authors:  J A Simpson
Journal:  Proc R Soc Med       Date:  1966-10

7.  Actions of triethylcholine on neuromuscular transmission.

Authors:  W C BOWMAN; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1961-10

8.  Effects of quaternary ammonium compounds on choline transport in red cells.

Authors:  K Martin
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

9.  ACTIONS OF HEMICHOLINIUM (HC-3) ON NEUROMUSCULAR TRANSMISSION.

Authors:  E R EVANS; H WILSON
Journal:  Br J Pharmacol Chemother       Date:  1964-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.